Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Depreciation and Depletion (2020 - 2024)

Historic Depreciation and Depletion for Dare Bioscience (DARE) over the last 5 years, with Q4 2024 value amounting to $6368.0.

  • Dare Bioscience's Depreciation and Depletion fell 3619.24% to $6368.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $42325.0, marking a year-over-year increase of 1032.77%. This contributed to the annual value of $42325.0 for FY2024, which is 1032.77% up from last year.
  • Dare Bioscience's Depreciation and Depletion amounted to $6368.0 in Q4 2024, which was down 3619.24% from $9742.0 recorded in Q3 2024.
  • Over the past 5 years, Dare Bioscience's Depreciation and Depletion peaked at $15437.0 during Q2 2024, and registered a low of $3034.0 during Q3 2022.
  • For the 5-year period, Dare Bioscience's Depreciation and Depletion averaged around $8726.5, with its median value being $9384.0 (2023).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first crashed by 5216.77% in 2022, then surged by 20520.76% in 2023.
  • Dare Bioscience's Depreciation and Depletion (Quarter) stood at $6799.0 in 2020, then increased by 3.65% to $7047.0 in 2021, then soared by 50.73% to $10622.0 in 2022, then dropped by 6.04% to $9980.0 in 2023, then plummeted by 36.19% to $6368.0 in 2024.
  • Its Depreciation and Depletion stands at $6368.0 for Q4 2024, versus $9742.0 for Q3 2024 and $15437.0 for Q2 2024.